What patients and families need to know
Genetics Expert Talks about Tensions Between Parents and Regulators over Duchenne Treatments
October 30, 2014
In a long feature story about the regulatory, economic, and personal impact of Duchenne muscular dystrophy, Eric Hoffman, PhD, Children's Research Institute, discusses the current tension that exists between families, wanting access to treatments and clinical trials, and the FDA.
For the Media
Find a Provider
Media Email Sign Up
Want the latest Children's National news and stories as they happen? Sign up to get our News & Events releases by email.